focus -WSS

focus

author：explore 2025-10-02 01:12:34 - browse：54455

A photograph of someone preparing small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at an in vitro fertilization lab — In vitro fertilization lab staff prepare small petri dishes, each holding embryos. (This sample image doesn't necessarily show embryos grown in media from CooperSurgical, a supply giant now facing lawsuits.) Michael Wyke/AP

Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos.

The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus. CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice, but it hasn’t disclosed exactly what went wrong. Lawsuits claim the media lacked magnesium, a key nutrient, while a Cooper representative told STAT the cause is still under investigation.

The recall could be a one-off manufacturing fluke. But the debacle, and the uncertainty around the problems with the fluid, sheds light on a larger problem: IVF doctors rarely know the exact composition of culture media in the first place. The Food and Drug Administration asks manufacturers for a list of materials before the media goes on the market, an FDA spokesperson told STAT. Companies will sometimes give clinics this information voluntarily, along with required labeling information like mouse embryo data, instructions for use, and warnings. But the FDA doesn’t require companies to list the ingredients or their proportions publicly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： With trial win, GSK could get blood cancer drug back on market

Wikipedia

WSS

Change Healthcare can notify patients about the breach, HHS says

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Ultragenyx gene therapy for rare liver ailment succeeds in late

Letters to First Opinion on caregivers, digital health, and more

House GOP plan to stem drug shortages differs from Democrats’

Intellia reports positive results for its CRISPR

hotspot

focus

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Adidas to release second batch of Yeezy sneakers after breakup with Ye

New air purifier tech could be key to improving indoor air quality

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Hepatitis C has a cure — but many Americans still lack access to it

5 wounded, 2 critically, in Michigan shopping center shooting

Malaria cases in Florida and Texas: Here’s what you need to know

Campaign finance charge dropped from case against Sam Bankman

The high cost of giving birth even with insurance

With trial win, GSK could get blood cancer drug back on market

focus

Intellia reports positive results for its CRISPR

Letters to First Opinion on caregivers, digital health, and more

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Shifting the focus from loneliness to social health

Many immigrants are left out of maternal health programs

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

focus

Wikipedia

explore

focus